Coming up this Friday is a follow up interview with BioViva CEO Liz Parrish!
Liz featured on one of our podcasts 2 years ago after she became one of the first people to attempt gene therapy, aiming to increase telomerase as well as taking a myostatin inhibitor. She is a pioneer in the fight against age related disease and recently partnered with IHS, meaning that gene therapy is gettingcloser to being available for everyone. This will be a very exciting update, we’ll be hearing all about her current achievements, future goals, directions, and ambitions.
If you have any questions let us know in the comments below!
Edited by onz, 13 March 2018 - 07:39 AM.